BeOne Medicines Ltd. — Director's Dealing 2022

Sep 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2022-09-20

Reporting Person: OYLER JOHN (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-20	American Depositary Shares	S	9749	$153.3184	Disposed	5511	Indirect
2022-09-20	American Depositary Shares	S	5411	$153.8057	Disposed	100	Indirect
2022-09-20	American Depositary Shares	S	100	$154.77	Disposed	0	Indirect
2022-09-20	American Depositary Shares	S	9748	$153.3184	Disposed	5512	Indirect
2022-09-20	American Depositary Shares	S	5412	$153.8057	Disposed	100	Indirect
2022-09-20	American Depositary Shares	S	100	$154.77	Disposed	0	Indirect
2022-09-21	American Depositary Shares	S	2000	$148.251	Disposed	7740	Indirect
2022-09-21	American Depositary Shares	S	2639	$149.2122	Disposed	5101	Indirect
2022-09-21	American Depositary Shares	S	2435	$150.3532	Disposed	2666	Indirect
2022-09-21	American Depositary Shares	S	1716	$151.163	Disposed	950	Indirect
2022-09-21	American Depositary Shares	S	500	$152.349	Disposed	450	Indirect
2022-09-21	American Depositary Shares	S	450	$153.1178	Disposed	0	Indirect
2022-09-21	American Depositary Shares	S	2000	$148.2512	Disposed	7740	Indirect
2022-09-21	American Depositary Shares	S	2638	$149.2121	Disposed	5102	Indirect
2022-09-21	American Depositary Shares	S	2436	$150.3532	Disposed	2666	Indirect
2022-09-21	American Depositary Shares	S	1716	$151.1633	Disposed	950	Indirect
2022-09-21	American Depositary Shares	S	500	$152.349	Disposed	450	Indirect
2022-09-21	American Depositary Shares	S	450	$153.1178	Disposed	0	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	2070913	Direct
Ordinary Shares	545597	Indirect
Ordinary Shares	7727927	Indirect
Ordinary Shares	29114115	Indirect
Ordinary Shares	9675000	Indirect
Ordinary Shares	102188	Indirect

Footnotes

F1: These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.

F2: These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

F3: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.

F4: These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.

F5: These securities are held by The John Oyler Legacy Trust, of which the Reporting Person's father is a trustee, for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.

F6: Each American Depositary Share represents 13 Ordinary Shares.

F7: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on March 7, 2022.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.56 to $153.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.56 to $154.39, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.69 to $154.85, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.81 to $148.72, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.81 to $149.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.81 to $150.79, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.81 to $151.63, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.84 to $152.82, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.

F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.885 to $153.40, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.